IQVIA has grown revenue 4.7% a year over three years and 6.7% a year over five, with earnings per share compounding at 13%. Revenue growth, 3-year annual rate: +4.7% (Diagnostics & Research median +8.4%). Revenue growth, 5-year rate: +6.7%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +13%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 15, FY2011 to FY2025, as filed.

IQVIQVIA

Healthcare

$259.96+37% 1Y

$259.96

$156.6652 weeks$275.17

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue roughly flat (+7% year on year) and earnings roughly flat (+10% year on year).

3 neutral

Revenue trend+7% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +7% a year.

Earnings trend+10% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction−0.9 points operating

Trailing-twelve-month operating margin, 13.2% now against 14.1% a year earlier.

All from SEC EDGAR, as of Mar 31, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsmiddle of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is IQV growing?

IQVIA has grown revenue 4.7% a year over three years and 6.7% a year over five, with earnings per share compounding at 13%.

+4.7%

Revenue growth, 3-year annual rate · Diagnostics & Research median +8.4% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +6.7%
Revenue growth, 5-year rate · +4.7% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +13%
Earnings per share, 3-year rate · revenue +4.7% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 15
Years of annual history on file · FY2011 to FY2025, as filed